Skip to Main Content Area
User login
Login using social networks
Username:
*
Password:
*
Remember me
Create new account
Request new password
Home
clinical stage
ATHX Athersys Initiated Overweight At Piper Jaffray ($1.67)
Athersys (NASDAQ: ATHX)
initiated overweight at
Piper Jaffray
($1.67).
Athersys
[+]
clinical stage
[+]
clinical stage biotechnology
[+]
inflammatory bowel disease
[+]
Medicine
[+]
Piper Jaffray
[+]
stroke
[+]
Read more
